<DOC>
	<DOCNO>NCT01705171</DOCNO>
	<brief_summary>In study investigate expression fructose transport protein GLUT5 small intestine patient functional GI disoders fructose intolerance compare match healthy control .</brief_summary>
	<brief_title>Is Expression GLUT5 Specific Fructose Transport Protein Abnormal Patients With Fructose Intolerance ?</brief_title>
	<detailed_description>Intolerances food major complaint patient functional gastrointestinal disorder ( FGID ) even common patient inflammatory bowel disorder ( IBD ) ( Barrett JS et al . Aliment Pharmacol Therap 2009 ; 30:165-174 ) . The common form food intolerance FODMAP ( fermentable oligo- , di- monosaccharide polyol ) -related , fructose lactose best know . The prevalence lactose fructose intolerance IBS patient 50 70 % ( Wilder-Smith CH et al . Gastroenterology 2009 ; 136 ( Suppl . 1 ) : A324 ) . Recent high quality study show reduction ingest FODMAP lead significant long-term symptom improvement patient show intolerant breath-testing . While pathophysiology behind lactose intolerance reduction small intestinal lactase availability , mechanism fructose intolerance relationship malabsorption unknown . One possible far uninvestigated mechanism reduction expression activity specific fructose transporter , GLUT5 , mainly responsible luminal absorption fructose . GLUT5 mainly find small intestine , well various extra-intestinal organ . The clinical relevance GLUT5 expression food intolerance human report , mouse model deletion GLUT5 lead decreased absorption dietary fructose typical sign malabsorption ( Barone S et al . J Biol Chem 2009 ; 284:5056-5066 ) . The control GLUT5 dynamic considerable upregulation together increased absorption fructose evident diabetes mellitus , expression decrease inflammation lipopolysaccharide endotoxin , integral component outer membrane gram-negative bacteria , action pro-inflammatory cytokine , TFN-a .</detailed_description>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Fructose Intolerance</mesh_term>
	<criteria>Patients refer practice evaluation symptom consistent FGID undergo upper GI endoscopy biopsy fructose breath test part usual clinical evaluation . Male female patient age 18 60 year FGID ( Irritable Bowel Syndrome ( IBS ) , Functional Dyspepsia ( FD ) Functional Bloating ( FB ) , define Rome III criterion . Successive patient without fructose intolerance undergo upper GI endoscopy reason without inflammatory disease Inflammatory GI disease , coeliac 's disease , relevant systemic disorder judge investigator , concomitant antiinflammtory treatment , absent inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>IBS</keyword>
	<keyword>fructose intolerance</keyword>
	<keyword>GLUT 5</keyword>
	<keyword>GLUT 2</keyword>
</DOC>